The National Agency for Food and Drug Administration and Control (NAFDAC) has ordered the immediate manufacturing of Chloroquine for emergency stock for possible clinical trial treatment of COVID-19
In a statement obtained by PREMIUM TIMES on Monday, the Director-General of the agency, Mojisola Adeyeye, said the old antimalarial is being repurposed for the clinical trial treatment of the virus.
There were early controversies surrounding the use of chloroquine as a treatment option for COVID-19.
President Donald Trump of the United States of America had on Thursday, March 19, announced that the U.S. had approved the anti-malaria drug, Chloroquine, for use as a treatment against the virus.
In a statement obtained by PREMIUM TIMES on Monday, the Director-General of the agency, Mojisola Adeyeye, said the old antimalarial is being repurposed for the clinical trial treatment of the virus.
Read more at https://www.premiumtimesng.com/news/top-news/384849-coronavirus-nafdac-orders-production-of-chloroquine-for-clinical-trial.html
